Form 4 Filing for Aquestive Therapeutics, Inc. - Lori J. Braender

This Form 4 filing details a grant of 82,500 Performance Stock Units (PSUs) to Lori J. Braender, Corporate Secretary of Aquestive Therapeutics, Inc., on March 7, 2025. Each PSU represents a contingent right to one share of common stock. The performance period for these PSUs is from March 7, 2025, to March 7, 2028, with vesting occurring on the final day if performance conditions are met. The performance price is determined by the 30-day average Nasdaq closing price over specified periods. The filing notes that this report was submitted late due to an inadvertent administrative oversight. The PSUs have an exercise price of $0.00 and an expiration date of March 7, 2028.